Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

Catalent said it will

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar

Plus, news about AnaptysBio, Alzamend, AEON Biopharma and argenx: iTeos Therapeutics’ $120M offering: The immuno-oncology company is selling about 1.1 million shares for $17.50 apiece. RA Capital

May 11, 2024

Omada Partners with Amazon Health Services to Boost Access to Virtual Cardiometabolic Care

What You Should Know: – Omada Health, a leading virtual-first healthcare provider, today announced a groundbreaking partnership with Amazon Health Services. This collaboration brings Omada’s

January 9, 2024

EC grants approval to Merck’s Keytruda regimen for gastric cancer

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.